GlassScriptPhysician profile
Vernon Earl Murphy
NPI 1174543227
$604.70
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.69 · 2020: $85.48 · 2021: $319 · 2022: $188.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $132.24 | 2021-2022 | |
| Pfizer INC. | $130.94 | 2020-2022 | |
| Novo Nordisk INC | $78.43 | 2021 | |
| Esperion Therapeutics, INC. | $46.35 | 2021-2022 | |
| Lilly USA, LLC | $38.87 | 2021 | |
| Novartis Pharmaceuticals Corporation | $29.54 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $17.73 | 2020 | |
| Mylan Specialty L.P. | $17.51 | 2021 | |
| Eisai INC. | $16.33 | 2021 | |
| Amgen INC. | $15.52 | 2022 | |
| Boston Scientific Corporation | $15.30 | 2020 | |
| Painteq LLC | $13.83 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.67 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.42 | 2021 | |
| Corcept Therapeutics | $13.33 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $11.69 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vernon Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.